Filing Details

Accession Number:
0001209191-14-073973
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-09 17:48:11
Reporting Period:
2014-12-05
Filing Date:
2014-12-09
Accepted Time:
2014-12-09 17:48:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1328143 Adamas Pharmaceuticals Inc ADMS Pharmaceutical Preparations (2834) 421560076
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604572 Natalie Mcclure C/O Adamas Pharmaceuticals, Inc.
1900 Powell St., Suite 750
Emeryville CA 94608
Svp, Product Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-05 2,000 $1.76 2,840 No 4 M Direct
Common Stock Disposition 2014-12-05 2,000 $14.01 840 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-12-05 2,000 $0.00 2,000 $1.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,666 2020-03-03 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $14.00 to $14.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The Option shares vested according to the following schedule: one-fifth (1/5th) of the shares vest one year after January 4, 2010; the balance of the shares vest in a series of forty-eight (48) successive equal monthly installments measured from the first anniversary of January 4, 2010, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2007 Stock Plan) as of each such date. The Option shares are subject to an early exercise right and may be exercised in full prior to vesting.